Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q4 FY26 results · Jan–Mar 2026
Max Healthcare Institute reported revenue from operations of ₹2,142.89 crore (up 12.2% from Q4 FY25) and net profit of ₹342.22 crore (up 7.3% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,142.89 | 1,909.74 | +12.2% | 2,067.52 | +3.6% |
| Other income | 47.83 | 46.92 | +1.9% | 45.38 | +5.4% |
| Total income | 2,190.72 | 1,956.66 | +12.0% | 2,112.90 | +3.7% |
| Profit before tax | 464.58 | 402.50 | +15.4% | 364.54 | +27.4% |
| Net profit for the period | 342.22 | 319.00 | +7.3% | 300.92 | +13.7% |
| EPS, basic (₹) | 3.52 | 3.28 | +7.3% | 3.10 | +13.5% |
| Net margin (%) | 16.0 | 16.7 | 14.6 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 732.90 | 658.70 | +11.3% | 710.91 | +3.1% |
| Other income | 91.34 | 98.15 | −6.9% | 83.33 | +9.6% |
| Total income | 824.24 | 756.85 | +8.9% | 794.24 | +3.8% |
| Profit before tax | 260.38 | 227.23 | +14.6% | 225.20 | +15.6% |
| Net profit for the period | 203.21 | 177.39 | +14.6% | 186.95 | +8.7% |
| EPS, basic (₹) | 2.09 | 1.82 | +14.8% | 1.92 | +8.9% |
| Net margin (%) | 27.7 | 26.9 | 26.3 |
Consolidated
- Filed with BSE
- 21 May 2026, 18:05 IST
- Board meeting
- 21 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 21 May 2026, 18:05 IST
- Board meeting
- 21 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE